Heart Attack News and Research

RSS

Specific antagonism lowers blood pressure

High blood pressure (hypertension) is associated with an increased risk of heart attack and stroke, and the frequent use of drugs known as NSAIDs, for example to treat individuals with rheumatoid arthritis, can cause hypertension.

17 Aug 2007

PET MPI provides a more accurate "picture" of coronary obstruction

Physicians need to know how badly heart vessels are blocked before they can decide how to treat patients at risk of having a heart attack.

17 Aug 2007

Diabetes increases risk of death for patients with acute coronary syndromes

Individuals with diabetes and acute coronary syndromes (ACS) such as a heart attack or unstable angina have an increased risk of death at 30 days and one year after ACS, compared with ACS patients without diabetes, according to a study in the August 15 issue of JAMA .

16 Aug 2007

Diovan (valsartan) granted pediatric exclusivity by FDA

Diovan (valsartan) has been granted pediatric exclusivity by the US Food and Drug Administration (FDA) based on studies conducted in children with high blood pressure.

13 Aug 2007

Writing off Avandia may be premature

Rosiglitazone, a drug marketed by GlaxoSmithKline as Avandia, for the treatment of type 2 diabetes, came under fire after an article published online May 21 by the New England Journal of Medicine linked it to significantly increased risk of heart attack and cardiovascular death.

12 Aug 2007

New player in the control of HDL cholesterol

Researchers have identified a new player in the control of so-called "good" cholesterol that circulates in the bloodstream and reduces heart attack risk, according to a report in the August issue of Cell Metabolism, a publication of Cell Press.

8 Aug 2007

Statin drugs may delay progressive artery damage in children

Starting statin therapy as young as age 8 safely and effectively delays the early artery damage caused by familial hypercholesterolemia (FH), according to a Dutch study reported in the Aug.7th print issue of Circulation: Journal of the American Heart Association.

7 Aug 2007

Many heart attack patients still not getting emergency reperfusion

Far more of today's heart attack patients receive emergency angioplasty treatment or clot-busting drugs to re-open their clogged heart arteries than even a decade ago, a new study finds.

6 Aug 2007

Emergency angioplasty use rises, but some patients still miss out

Compared with their counterparts a decade ago, today's heart attack patients are receiving emergency angioplasty or clot-busting drugs to re-open clogged arteries at a far greater rate, but 10 percent of patients who could benefit from this life-saving treatment still do not receive it, according to a study published in The American Journal of Medicine by Yale and University of Michigan researchers.

6 Aug 2007

Age is important in HRT use

Five years ago this summer the National Institutes of Health's stopped early a major portion of the Women's Health Initiative (WHI), a large and ambitious study to address the most common causes of death, disability and impaired quality of life in postmenopausal women.

3 Aug 2007

Integrated system, rapid transfer offers lifeline for heart attack victims

Heart attack patients received lifesaving treatment quickly when hospitals and communities used an integrated, rapid transfer system to get patients to a facility equipped to perform artery-opening procedures, according to a report in Circulation: Journal of the American Heart Association.

3 Aug 2007

New heart attack test assessed

New research commissioned by the National Institute for Health Research's Health Technology Assessment (NIHR HTA) programme is investigating a new blood test for helping diagnose or rule out heart attacks.

2 Aug 2007

New oral contraceptive means 365 period free days a year

Women in the United States can now access the first low-dose combination contraceptive pill which stops their periods.

31 Jul 2007

Trans fats offer a double whammy

Along with the knowledge that 'trans fats' are particularly bad because they clog up arteries and increase the risk of heart attacks comes new information which makes them even more undesirable.

31 Jul 2007

Takeda responds to FDA recommendation on Actos

Following a joint meeting today of the U.S. Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee, Takeda Global Research & Development (TGRD) underscores its position that ACTOS(R) (pioglitazone HCl) offers a proven safety profile regarding the risk of cardiovascular disease.

30 Jul 2007

Avandia too risky says expert

One of the members of the advisory panel set up to discuss the future of the diabetes pill Avandia says it should be removed from the market because it is too risky and offers no advantage over other alternatives.

30 Jul 2007

Polypill cure-for-all could become a killer

Doctors in Britain are warning that offering all men over 50 and all women over 60 a pill to protect them against heart disease and stroke, will only serve to encourage an unhealthy lifestyle.

30 Jul 2007

Thiazolinediones increase risk of heart failure

A class of drugs commonly used to treat type 2 diabetes may double the risk of heart failure, according to a new analysis by researchers at Wake Forest University School of Medicine and colleagues.

27 Jul 2007

Air pollution has a role to play in atherosclerosis

Should we be watching our exposure to airborne pollution as well as our cholesterol levels?

26 Jul 2007

Metformin gets top grade for diabetes

A type 2 diabetes drug taken orally and in widespread use for more than a decade has been found to have distinct advantages over nine other, mostly newer medications used to control the chronic disease, according to a study by researchers at Johns Hopkins.

26 Jul 2007